Natco Pharma
 | |
| Type | Public company |
|---|---|
| NSE: NATCOPHARM BSE: 524816 | |
| Industry | Pharmaceuticals |
| Founded | 1981 |
| Founders | VC Nannapaneni |
| Headquarters | , |
Area served | Global |
Key people | VC Nannapaneni (Chairman and MD)[1] Rajeev Nannapaneni (CEO and Vice Chairman)[2] |
| Website | natcopharma.co.in |
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad, which makes finished dosage formulations and active pharmaceutical ingredients. It is the market leader in branded oncology medicines in India,[3] and among the country's top three producers of hepatitis C drugs.[4]
In 2003, Natco Pharma launched Veenat, a generic version of Novartis AG's anti-cancer drug Glivec. It won the subsequent patent protection legal battle against Novartis in 2013.[5] In 2012, Natco Pharma obtained compulsory license to produce a cheaper and generic version of Bayer's anti-cancer medication Nexavar.[4] In 2017, Natco Pharma launched a generic version of blood cancer drug Pomalidomide at a 98% discount to the drug's selling price in the United States.[6]
In the United States, it launched influenza medication Tamiflu with marketing partner Alvogen, multiple sclerosis treatment drug glatiramer acetate in partnership with Mylan, and hepatitis C drugs under a licensing agreement with Gilead Sciences.[5]
References[]
- ^ "Facing headwinds in US, Natco Pharma looks to scale up business in China". Livemint. Retrieved 19 April 2020.
- ^ "Natco Pharma: In fine fettle". Forbes India. Retrieved 19 April 2020.
- ^ "Natco Pharma lines up 20 `Para IV' products". The Hindu Business Line. Retrieved 19 April 2020.
- ^ Jump up to: a b "How Natco defied the odds to rise up India's pharma ladder". Moneycontrol. Retrieved 19 April 2020.
- ^ Jump up to: a b "Niche Play". Business Today. Retrieved 19 April 2020.
- ^ "Natco Pharma launches blood cancer drug priced Rs 5,000–20,000, down 98% from US price – Business News , Firstpost". Firstpost. 10 May 2017. Retrieved 31 July 2020.
Authority control  |
|
|---|
  | This article about an Indian company is a stub. You can help Wikipedia by . |
 | This corporation or company article is a stub. You can help Wikipedia by . |
- Indian company stubs
- Pharmaceutical companies of India
- Manufacturing companies based in Hyderabad, India
- Pharmaceutical companies established in 1981
- 1981 establishments in Andhra Pradesh
- Indian companies established in 1981
- Companies listed on the National Stock Exchange of India
- Companies listed on the Bombay Stock Exchange
- Company stubs